Articles

T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma

Research Program Unit, Medical Faculty, University of Helsinki, Finland;Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Research Program Unit, Medical Faculty, University of Helsinki, Finland;Department of Oncology, Tampere University Hospital, Finland
Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki, Finland
Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland
Research Program Unit, Medical Faculty, University of Helsinki, Finland;Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Department of Pathology, Helsinki University Hospital, Finland
Research Program Unit, Medical Faculty, University of Helsinki, Finland;Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Department of Oncology, Tampere University Hospital, Finland;University of Tampere, Faculty of Medicine and Life Sciences, Finland
Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland;Science for Life Laboratory, Karolinska Institutet, Department of Oncology and Pathology, Solna, Sweden
Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki, Finland;Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Research Program Unit, Medical Faculty, University of Helsinki, Finland;Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Vol. 104 No. 2 (2019): February, 2019 https://doi.org/10.3324/haematol.2018.200105